Dublin, April 12, 2023 (GLOBE NEWSWIRE) -- The "Global Cardiac Rhythm Management Devices" report has been added to ResearchAndMarkets.com's offering.

This study provides an overview of global cardiac rhythm management (CRM) devices, covering pacemakers, implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy (CRT) devices, and implantable cardiac monitors (ICMs).

It offers a detailed analysis of market sizing, trends, competitive landscape, future market outlook by region, and growth opportunities.

This study focuses on technology, connectivity, continuous monitoring, and new pathways for CRM. The competitive analysis includes company market shares for traditional CRM devices, and the market sizing analysis covers historical and forecast revenue and volume data by region and segment.

The report aims to understand the future focus of companies on the innovation of solution/business models for low disruption and high impact on workflow with:

Key Topics Covered:

1 Strategic Imperatives

2 Growth Opportunity Analysis

3 Growth Opportunity Analysis: Pacemakers

4 Growth Opportunity Analysis: Implantable Cardiac Defibrillators

5 Growth Opportunity Analysis: Cardiac Resynchronization Therapy Devices

6 Growth Opportunity Analysis: Implantable Cardiac Monitors

7 Changing Trends in CRM Industry

8 Growth Opportunity Universe

9 Next Steps

For more information about this report visit https://www.researchandmarkets.com/r/64n1e4

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.